Biomaterials and cell-based therapy post spinal cord injury

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cell Biology

Background:

• Spinal cord injury (SCI) presents significant global health challenges, with limited sustained recovery despite medical advancements.
• Cell-based therapies are emerging as a promising avenue for neuroprotection and neuro-regeneration following SCI.

Purpose of the Study:

• To review promising preclinical cell-based therapies for spinal cord injury.
• To discuss ancillary strategies that enhance cell therapy efficacy.
• To highlight SCI pathophysiology and the biology of cell treatments.

Main Methods:

• Review of preclinical research on various cell transplantation strategies for SCI.
• Examination of stem cell types including ESCs, MSCs, NSCs, OPCs, SCs, and OECs.
• Analysis of supportive techniques like trophic factors, biomaterials, and synergistic treatments.

Main Results:

• Multiple cell types (ESCs, MSCs, NSCs, OPCs, SCs, OECs) demonstrate potential in preclinical SCI models.
• Ancillary strategies such as trophic factors and biomaterial scaffolds can improve graft survival and function.
• Combined approaches show promise for enhanced neuronal regeneration and reduced glial scarring.

Conclusions:

• Cell-based therapies offer a viable strategy for addressing the limitations in SCI recovery.
• Optimizing cell type, delivery, and supportive microenvironments is crucial for therapeutic success.
• Further research into synergistic treatments is needed to translate preclinical findings into clinical applications for SCI.